Summary
Given the recent attention on pharmacy benefits managers (PBMs) in the House and Senate, WHG has developed the following chart that examines current PBM legislation under consideration. Additional details on each policy area can be found in the attached chart.
| Bill | Transparency Requirements | Banning Spread Pricing | Rebate Passthrough | Improved Beneficiary Out-of-Pocket Costs | PBM Reimbursement |
| S____, The Pharmacy Benefit Manager Reform Act
|
Yes | Yes | Yes | No | No |
| The SFC PBM Legislative Framework
|
Yes | Yes | Yes | No | Yes |
| H.R. 2679, the PBM Accountability Act
|
Yes | No | No | No | No |
| H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023
|
Yes | Yes | No | No | No |
| H.R.___, patient protections for highly rebated drugs
|
No | No | No | Yes | No |
| H.R.___, to amend title XVIII of the Social Security Act to promote transparency of common ownership interests under parts C and D of the Medicare program
|
Yes | No | No | No | No |
| H.R. 2816, the PBM Sunshine and Accountability Act
|
Yes | No | No | No | No |
| H.R. 830, the Help Ensure Lower Patient (HELP) Copays Act
|
No | No | No | Yes | No |